Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins
- PMID: 6219982
- DOI: 10.1093/jac/11.2.200
Comparison of in-vitro activity of latamoxef (moxalactam) and ceftazidime against Pseudomonas and Enterobacteriaceae resistant to first generation cephalosporins
Similar articles
-
In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.Antimicrob Agents Chemother. 1982 Jan;21(1):188-91. doi: 10.1128/AAC.21.1.188. Antimicrob Agents Chemother. 1982. PMID: 6282206 Free PMC article.
-
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.Antimicrob Agents Chemother. 1980 Jun;17(6):937-42. doi: 10.1128/AAC.17.6.937. Antimicrob Agents Chemother. 1980. PMID: 6250470 Free PMC article.
-
The in vitro activity of ceftazidime against resistant clinical isolates.Infection. 1983;11 Suppl 1:S23-7. doi: 10.1007/BF01641101. Infection. 1983. PMID: 6299967
-
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.Annu Rev Pharmacol Toxicol. 1982;22:599-642. doi: 10.1146/annurev.pa.22.040182.003123. Annu Rev Pharmacol Toxicol. 1982. PMID: 6282190 Review. No abstract available.
-
Ceftazidime review.Drug Intell Clin Pharm. 1985 Jul-Aug;19(7-8):509-13. doi: 10.1177/106002808501900701. Drug Intell Clin Pharm. 1985. PMID: 3896712 Review.
Cited by
-
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002. Drugs. 1985. PMID: 3884319 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources